Michael De Felippis PhD Eli Lilly and Company
Michael De Felippis PhD Eli Lilly and Company Senior Vice President - Research Bioproduct Research and Development
Michael R. De Felippis, Ph.D. is a Senior Vice President - Research in the Bioproduct Research and Development Organization of Eli Lilly and Company. He is responsible for providing strategic scientific oversight of the CMC activities for the biopharmaceutical product portfolio with emphasis on analytical, process and product development, control strategy definition, and preparation of CMC-related regulatory documentation supporting global licensure. Professional activities external to Lilly include member of the USP Council of Experts, Chair of the USP Expert Committee on Therapeutic Peptides and Oligonucleotides, member of the European Pharmacopoeia Gene Therapy Products Working Party, and member of the EFPIA ATMP Manufacturing and GMP Sub-team.